Oxybutynin and Tracheal inflammation - a phase IV clinical study of FDA data

Summary:

Tracheal inflammation is reported only by a few people who take Oxybutynin.

The phase IV clinical study analyzes which people take Oxybutynin and have Tracheal inflammation. It is created by eHealthMe based on reports of 19,517 people who have side effects while taking Oxybutynin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 28, 2023

19,517 people reported to have side effects when taking Oxybutynin.
Among them, 2 people (0.01%) have Tracheal inflammation.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 19,788 Oxybutynin users for its effectiveness, alternative drugs and more.

What is Tracheal inflammation?

Tracheal inflammation (inflammation of trachea) is found to be associated with 145 drugs and 71 conditions by eHealthMe.

Number of Oxybutynin and Tracheal inflammation reports submitted per year:

Could Oxybutynin cause Tracheal inflammation?

Gender of people who have Tracheal inflammation when taking Oxybutynin *:

female: 100 %
male: 0.0 %

Age of people who have Tracheal inflammation when taking Oxybutynin *:

Common drugs people take besides Oxybutynin *:

Xolair: 2 people, 100.00%

Common side effects people have besides Tracheal inflammation *:

Weight Fluctuation: 2 people, 100.00%
Laryngeal Inflammation (infection of larynx): 2 people, 100.00%
Angioedema (rapid swelling of the dermis): 2 people, 100.00%
Antinuclear Antibody Positive: 2 people, 100.00%
Blepharitis (chronic inflammation of the eyelid): 2 people, 100.00%
Blindness: 2 people, 100.00%
Breathing Difficulty: 2 people, 100.00%
Eating Disorder: 2 people, 100.00%
Haemoglobin Decreased: 2 people, 100.00%
Hepatic Function Abnormal: 2 people, 100.00%

Common conditions people have *:

Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 50.00%
Mixed Connective Tissue Disease (an autoimmune disease, in which the body's defence system attacks itself): 1 person, 50.00%
Angioedema (rapid swelling of the dermis): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Oxybutynin and have Tracheal inflammation?

Check whether Tracheal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Tracheal inflammation and when was it recovered:

Tracheal inflammation in Oxybutynin

Expand to all the drugs that have ingredients of oxybutynin:

Tracheal inflammation and drugs with ingredients of oxybutynin

Alternative drugs to, pros and cons of Oxybutynin:

Oxybutynin (19,788 reports)

Common Oxybutynin side effects:

Fatigue (feeling of tiredness): 1,576 reports
Drug ineffective: 1,529 reports
Urinary tract infection: 1,145 reports
Weakness: 1,129 reports
Diarrhea: 1,044 reports
Pain: 963 reports
Dizziness: 944 reports
Headache (pain in head): 909 reports

Browse all side effects of Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Tracheal inflammation treatments and more:

Tracheal inflammation (121 reports)

COVID vaccines that are related to Tracheal inflammation:

All the drugs that are associated with Tracheal inflammation:

Tracheal inflammation (145 drugs)

All the conditions that are associated with Tracheal inflammation:

Tracheal inflammation (71 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin (the active ingredients of Oxybutynin) and Oxybutynin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.